SOPHARMA AD - Notification for buy-back of treasury shares

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_buyback_08122023_espi.pdf
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 210 / 2023

Date of issue: 2023-12-07

Short name of the issuer

SOPHARMA AD

Subject

Notification for buy-back of treasury shares

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Pursuant to the requirements of Art. 100t of the Law on Public Offering of Securities, "Sopharma" AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) announces that on the basis of Art. 187b of the Commercial Law and Art. 111, para. 5 and para. 6 of the Law on Public Offering of Securities and in connection with the decision of the General Meeting of Shareholders of the company, held on 4 August 2023, and the decision of the Board of Directors of the company from 7 December 2023, "Sopharma" AD notifies that the company intends to buy back treasury shares within the limit according to Art. 111, para. 5 of the Law on Public Offering of Securities.

Annexes

File Description

SFA_buyback_08122023_espi.pdf
SFA_buyback_08122023_espi.pdf

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-12-07 Ognian Ivanov Donev Executive director